7774.T JPX
Japan Tissue Engineering Co., Ltd.
1W: -1.8%
1M: -3.6%
3M: +33.5%
YTD: +40.2%
1Y: +56.0%
3Y: +46.4%
5Y: +7.3%
¥831.00 ($5.27)
-2.00 (-0.24%)
Weekly Expected Move ±8.3%
¥695
¥764
¥833
¥902
¥971
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$2.5B
-2.3% ▼
5Y CAGR: +1.2%
Gross Profit
$1.5B
-10.6% ▼
5Y CAGR: +4.9%
Operating Income
-$238M
-264.9% ▼
Net Income
-$255M
-278.3% ▼
EPS (Diluted)
$-6.29
-278.2% ▼
EBITDA
-$76M
-127.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $2.3B | $2.1B | $2.0B | $2.5B | $2.5B |
| YoY Growth | -2.3% | -6.8% | -3.4% | +23.7% | -2.3% |
| Cost of Revenue | $1.1B | $848M | $896M | $824M | $944M |
| Gross Profit | $1.2B | $1.3B | $1.1B | $1.7B | $1.5B |
| Gross Margin | 51.2% | 59.7% | 55.9% | 67.2% | 61.5% |
| R&D Expenses | $469M | $562M | $573M | $407M | $507M |
| SG&A Expenses | $1.1B | $1.1B | $1.2B | $1.1B | $1.1B |
| Operating Expenses | $1.6B | $1.8B | $1.9B | $1.5B | $1.7B |
| Operating Income | -$467M | -$498M | -$728M | $145M | -$238M |
| Operating Margin | -20.7% | -23.7% | -35.8% | 5.7% | -9.7% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$463M | -$494M | -$725M | $147M | -$234M |
| Tax Expense | $4M | $4M | $4M | $4M | $21M |
| Net Income | -$467M | -$498M | -$729M | $143M | -$255M |
| Net Margin | -20.7% | -23.7% | -35.9% | 5.7% | -10.4% |
| EPS (Diluted) | $-11.49 | $-12.26 | $-17.96 | $3.53 | $-6.29 |
| EBITDA | -$339M | -$374M | -$597M | $279M | -$76M |
| Shares Outstanding | 41M | 41M | 41M | 41M | 41M |